NCT00985959 · OUTCOME
Maximum Observed Plasma Concentration (Cmax) of Prednisolone - Phase I
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- ng/mL
- Interval / dispersion
- Standard Deviation
- Time frame
- Day 4 of Cycle 2
What was measured
Cmax of Prednisolone at dose of 60 mg/m2 on Cycle 2/Day 4
Analysis population: Pharmacokinetics-evaluable population: 14 participants were included in pharmacokinetics-evaluable population during Cycle 2
Groups in this outcome
Prednisolone
Prednisolone 60 mg/m2 on day 1, 2, 3 and 4 of 6-week cycle up to 9 cycles
| Group | Source count |
|---|---|
| Prednisolone | 14 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Prednisolone | 1131 | 223.92 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 223.92
- value
- 1131
- denoms
- counts
- group Id
- OG000
- value
- 14
- units
- Participants
- description
- Cmax of Prednisolone at dose of 60 mg/m2 on Cycle 2/Day 4
- dispersion Type
- Standard Deviation
- groups
- description
- Prednisolone 60 mg/m2 on day 1, 2, 3 and 4 of 6-week cycle up to 9 cycles
- id
- OG000
- title
- Prednisolone
- param Type
- MEAN
- population Description
- Pharmacokinetics-evaluable population: 14 participants were included in pharmacokinetics-evaluable population during Cycle 2
- reporting Status
- POSTED
- time Frame
- Day 4 of Cycle 2
- title
- Maximum Observed Plasma Concentration (Cmax) of Prednisolone - Phase I
- type
- SECONDARY
- unit Of Measure
- ng/mL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle